Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

31 oct. 2025 05h11 HE | Source: Research and Markets

Hemophilia A (Factor VIII Deficiency) Global Clinical Trials Market Review 2025: Hemlibra Demonstrates Exercise-Related Bleeding Prevention as Pfizer Reports Positive Phase III BAISIS Trial Results

Dublin, Oct. 31, 2025 (GLOBE NEWSWIRE) -- The "Hemophilia A (Factor VIII Deficiency) - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.This...
30 déc. 2020 09h08 HE | Source: Research and Markets

Hemlibra (Emicizumab-kxwh): A Bispecific Factor IXa- and Factor X-directed Antibody - Global Drug Insight and Market Forecasts 2017-2030

Dublin, Dec. 30, 2020 (GLOBE NEWSWIRE) -- The "Hemlibra (Emicizumab-kxwh) - Drug Insight and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering. Hemlibra - Drug...